ONO-3849 Phase II Study
Phase 2
- Conditions
- Opioid-induced constipation
- Registration Number
- JPRN-jRCT2080221726
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1.Age 20 years or older.
2.Patient with constipation on a stable opioid regimen.
Exclusion Criteria
1.Patients with known or suspected gastrointestinal obstruction.
2.Patients with constipation mainly caused by any bowel dysfunction other than opioid-induced one.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method